Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research note published on Tuesday. The brokerage issued a buy rating on the stock.

Mannatech Stock Up 8.1 %

MTEX opened at $8.50 on Tuesday. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $10.51. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The company has a fifty day moving average of $7.88 and a two-hundred day moving average of $7.57. The stock has a market capitalization of $15.98 million, a price-to-earnings ratio of -10.49 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The company had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.

Insider Transactions at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares of the company’s stock, valued at $424,087.75. The trade was a 22.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.